214 related articles for article (PubMed ID: 35820809)
1. Copy number variation at the 22q11.2 locus influences prevalence, severity, and psychiatric impact of sleep disturbance.
O'Hora KP; Lin A; Kushan-Wells L; Bearden CE
J Neurodev Disord; 2022 Jul; 14(1):41. PubMed ID: 35820809
[TBL] [Abstract][Full Text] [Related]
2. Distinct neurocognitive profiles and clinical phenotypes associated with copy number variation at the 22q11.2 locus.
O'Hora KP; Kushan-Wells L; Schleifer CH; Cruz S; Hoftman GD; Jalbrzikowski M; Gur RE; Gur RC; Bearden CE
Autism Res; 2023 Dec; 16(12):2247-2262. PubMed ID: 37997544
[TBL] [Abstract][Full Text] [Related]
3. Distinct Neurocognitive Profiles and Clinical Phenotypes Associated with Copy Number Variation at the 22q11.2 Locus.
O'Hora KP; Kushan-Wells L; Hoftman GD; Jalbrzikowski M; Gur RC; Gur R; Bearden CE
medRxiv; 2023 May; ():. PubMed ID: 37292882
[TBL] [Abstract][Full Text] [Related]
4. Effects of gene dosage and development on subcortical nuclei volumes in individuals with 22q11.2 copy number variations.
Schleifer CH; O'Hora KP; Fung H; Xu J; Robinson TA; Wu AS; Kushan-Wells L; Lin A; Ching CRK; Bearden CE
Neuropsychopharmacology; 2024 May; 49(6):1024-1032. PubMed ID: 38431758
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal Copy Number Variations at 22q11.2 Produce Distinct and Convergent Neurobehavioral Impairments Relevant for Schizophrenia and Autism Spectrum Disorder.
Lin A; Vajdi A; Kushan-Wells L; Helleman G; Hansen LP; Jonas RK; Jalbrzikowski M; Kingsbury L; Raznahan A; Bearden CE
Biol Psychiatry; 2020 Aug; 88(3):260-272. PubMed ID: 32143830
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal trajectories of cortical development in 22q11.2 copy number variants and typically developing controls.
Jalbrzikowski M; Lin A; Vajdi A; Grigoryan V; Kushan L; Ching CRK; Schleifer C; Hayes RA; Chu SA; Sugar CA; Forsyth JK; Bearden CE
Mol Psychiatry; 2022 Oct; 27(10):4181-4190. PubMed ID: 35896619
[TBL] [Abstract][Full Text] [Related]
7. Effects of Gene Dosage and Development on Subcortical Nuclei Volumes in Individuals with 22q11.2 Copy Number Variations.
Schleifer CH; O'Hora KP; Fung H; Xu J; Robinson TA; Wu AS; Kushan-Wells L; Lin A; Ching CRK; Bearden CE
bioRxiv; 2023 Nov; ():. PubMed ID: 37961662
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic profiling of whole blood in 22q11.2 reciprocal copy number variants reveals that cell proportion highly impacts gene expression.
Lin A; Forsyth JK; Hoftman GD; Kushan-Wells L; Jalbrzikowski M; Dokuru D; Coppola G; Fiksinski A; Zinkstok J; Vorstman J; Nachun D; Bearden CE
Brain Behav Immun Health; 2021 Dec; 18():100386. PubMed ID: 34841284
[TBL] [Abstract][Full Text] [Related]
9. Risk of Psychiatric Disorders Among Individuals With the 22q11.2 Deletion or Duplication: A Danish Nationwide, Register-Based Study.
Hoeffding LK; Trabjerg BB; Olsen L; Mazin W; Sparsø T; Vangkilde A; Mortensen PB; Pedersen CB; Werge T
JAMA Psychiatry; 2017 Mar; 74(3):282-290. PubMed ID: 28114601
[TBL] [Abstract][Full Text] [Related]
10. Mapping 22q11.2 Gene Dosage Effects on Brain Morphometry.
Lin A; Ching CRK; Vajdi A; Sun D; Jonas RK; Jalbrzikowski M; Kushan-Wells L; Pacheco Hansen L; Krikorian E; Gutman B; Dokoru D; Helleman G; Thompson PM; Bearden CE
J Neurosci; 2017 Jun; 37(26):6183-6199. PubMed ID: 28536274
[TBL] [Abstract][Full Text] [Related]
11. 22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening.
Wenger TL; Miller JS; DePolo LM; de Marchena AB; Clements CC; Emanuel BS; Zackai EH; McDonald-McGinn DM; Schultz RT
Mol Autism; 2016; 7():27. PubMed ID: 27158440
[TBL] [Abstract][Full Text] [Related]
12. Evidence that duplications of 22q11.2 protect against schizophrenia.
Rees E; Kirov G; Sanders A; Walters JT; Chambert KD; Shi J; Szatkiewicz J; O'Dushlaine C; Richards AL; Green EK; Jones I; Davies G; Legge SE; Moran JL; Pato C; Pato M; Genovese G; Levinson D; Duan J; Moy W; Göring HH; Morris D; Cormican P; Kendler KS; O'Neill FA; Riley B; Gill M; Corvin A; ; Craddock N; Sklar P; Hultman C; Sullivan PF; Gejman PV; McCarroll SA; O'Donovan MC; Owen MJ
Mol Psychiatry; 2014 Jan; 19(1):37-40. PubMed ID: 24217254
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study.
Olsen L; Sparsø T; Weinsheimer SM; Dos Santos MBQ; Mazin W; Rosengren A; Sanchez XC; Hoeffding LK; Schmock H; Baekvad-Hansen M; Bybjerg-Grauholm J; Daly MJ; Neale BM; Pedersen MG; Agerbo E; Mors O; Børglum A; Nordentoft M; Hougaard DM; Mortensen PB; Geschwind DH; Pedersen C; Thompson WK; Werge T
Lancet Psychiatry; 2018 Jul; 5(7):573-580. PubMed ID: 29886042
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study.
Chawner SJRA; Owen MJ; Holmans P; Raymond FL; Skuse D; Hall J; van den Bree MBM
Lancet Psychiatry; 2019 Jun; 6(6):493-505. PubMed ID: 31056457
[TBL] [Abstract][Full Text] [Related]
15. Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes.
Vysotskiy M; Zhong X; Miller-Fleming TW; Zhou D; ; ; ; Cox NJ; Weiss LA
Genome Med; 2021 Oct; 13(1):172. PubMed ID: 34715901
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
Rogdaki M; Devroye C; Ciampoli M; Veronese M; Ashok AH; McCutcheon RA; Jauhar S; Bonoldi I; Gudbrandsen M; Daly E; van Amelsvoort T; Van Den Bree M; Owen MJ; Turkheimer F; Papaleo F; Howes OD
Mol Psychiatry; 2023 May; 28(5):1995-2006. PubMed ID: 33981004
[TBL] [Abstract][Full Text] [Related]
17. Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity.
Sefik E; Guest RM; Aberizk K; Espana R; Goines K; Novacek DM; Murphy MM; Goldman-Yassen AE; Cubells JF; Ousley O; Li L; Shultz S; Walker EF; Mulle JG
Psychiatry Res; 2024 May; 335():115867. PubMed ID: 38537595
[TBL] [Abstract][Full Text] [Related]
18. Sleep disturbances and emotional dysregulation in young children with autism spectrum, intellectual disability, or global developmental delay.
Favole I; Davico C; Marcotulli D; Sodero R; Svevi B; Amianto F; Ricci FS; Arduino GM; Vitiello B
Sleep Med; 2023 May; 105():45-52. PubMed ID: 36963320
[TBL] [Abstract][Full Text] [Related]
19. Sleep in 22q11.2 Deletion Syndrome: Current Findings, Challenges, and Future Directions.
O'Hora KP; Schleifer CH; Bearden CE
Curr Psychiatry Rep; 2023 Oct; 25(10):479-491. PubMed ID: 37721640
[TBL] [Abstract][Full Text] [Related]
20. Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis.
Amir CM; Kapler S; Hoftman GD; Kushan L; Zinberg J; Cadenhead KS; Kennedy L; Cornblatt BA; Keshavan M; Mathalon DH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD; Addington J; Bearden CE
Front Psychiatry; 2023; 14():1143315. PubMed ID: 37151981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
